Bolt Biotherapeutics Growth Metrics (2020-2026) | BOLT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)						0.21M	0.40M	0.22M	0.04M	0.04M	0.05M	0.07M	-0.04M	-0.07M		-0.07M	0.12M	0.10M		-2.69M
EBITDA Margin Growth (3y) (Quarter)								0.44M	1.52M					0.18M		0.21M	0.12M	0.07M	0.11M	-2.69M
EBITDA Margin Growth (5y) (Quarter)																0.44M	1.60M
EBITDA Margin (QoQ) (Quarter)			-0.23M	0.24M	0.14M	0.06M	-0.03M	0.05M	-0.04M	0.06M	-0.02M	0.06M	-0.15M	0.04M			0.04M	0.01M	0.01M	-2.76M
EBIT Margin Growth (1y) (Quarter)						0.21M	0.38M	0.19M	0.03M	0.03M	0.05M	0.07M	-0.04M	-0.07M		-0.07M	0.13M	0.11M		-2.82M
EBIT Margin Growth (3y) (Quarter)								0.43M	1.52M					0.17M		0.19M	0.11M	0.07M	0.12M	-2.82M
EBIT Margin Growth (5y) (Quarter)																0.43M	1.61M
EBIT Margin (QoQ) (Quarter)			-0.22M	0.24M	0.13M	0.06M	-0.04M	0.05M	-0.04M	0.07M	-0.02M	0.06M	-0.14M	0.03M			0.05M	0.02M	0.01M	-2.90M
EBT Margin Growth (1y) (Quarter)						0.21M	0.39M	0.20M	0.04M	0.04M	0.06M	0.06M	-0.04M	-0.07M		-0.06M	0.12M	0.10M		-2.73M
EBT Margin Growth (3y) (Quarter)								0.43M	1.52M					0.18M		0.20M	0.11M	0.07M	0.11M	-2.72M
EBT Margin Growth (5y) (Quarter)																0.44M	1.60M
EBT Margin (QoQ) (Quarter)			-0.22M	0.24M	0.13M	0.06M	-0.04M	0.05M	-0.03M	0.06M	-0.02M	0.06M	-0.14M	0.03M			0.04M	0.01M	0.01M	-2.79M
Enterprise Value Growth (1y) (Quarter)	-440.73%	-1,096.50%	-715.39%	28.41%	28.02%	19.62%	9.31%	33.80%	28.62%	30.04%	93.60%	27.72%	41.45%	55.06%	26.10%	89.96%	0.04%	40.69%	-244.29%	-28.71%
Enterprise Value Growth (3y) (Quarter)								-121.60%	-40.58%	-88.79%	22.07%	30.03%	33.00%	36.78%	64.99%	63.64%	25.24%	42.87%	45.39%	54.62%
Enterprise Value Growth (5y) (Quarter)																4.61%	-10.21%	-12.39%	-3.79%	46.39%
Enterprise Value (QoQ) (Quarter)	8.13%	13.10%	12.53%	-2.51%	7.63%	2.95%	1.31%	25.17%	0.41%	4.88%	90.97%	-745.05%	19.32%	27.00%	85.15%	-14.85%	-702.92%	56.68%	13.80%	57.07%
FCF Margin Growth (1y) (Quarter)						0.19M	0.23M	0.18M	0.04M	-0.00M	0.06M	0.10M	-0.02M	-0.06M		-0.08M	0.07M	0.08M		-2.98M
FCF Margin Growth (3y) (Quarter)								0.46M	1.90M					0.13M		0.20M	0.09M	0.02M	0.10M	-2.96M
FCF Margin Growth (5y) (Quarter)																0.48M	1.96M
FCF Margin (QoQ) (Quarter)			-0.10M	0.05M	0.16M	0.08M	-0.06M	-0.00M	0.02M	0.04M	-0.00M	0.04M	-0.10M	0.00M			0.06M	0.01M	0.02M	-3.06M
Net Margin Growth (1y) (Quarter)						0.21M	0.39M	0.20M	0.04M	0.04M	0.06M	0.06M	-0.04M	-0.07M		-0.06M	0.12M	0.10M		-2.73M
Net Margin Growth (3y) (Quarter)								0.43M	1.52M					0.18M		0.20M	0.11M	0.07M	0.11M	-2.72M
Net Margin Growth (5y) (Quarter)																0.44M	1.60M
Net Margin (QoQ) (Quarter)			-0.22M	0.24M	0.13M	0.06M	-0.04M	0.05M	-0.03M	0.06M	-0.02M	0.06M	-0.14M	0.03M			0.04M	0.01M	0.01M	-2.79M
Operating Margin Growth (1y) (Quarter)						0.21M	0.38M	0.19M	0.03M	0.03M	0.05M	0.07M	-0.04M	-0.07M		-0.07M	0.13M	0.11M		-2.82M
Operating Margin Growth (3y) (Quarter)								0.43M	1.52M					0.17M		0.19M	0.11M	0.07M	0.12M	-2.82M
Operating Margin Growth (5y) (Quarter)																0.43M	1.61M
Operating Margin (QoQ) (Quarter)			-0.22M	0.24M	0.13M	0.06M	-0.04M	0.05M	-0.04M	0.07M	-0.02M	0.06M	-0.14M	0.03M			0.05M	0.02M	0.01M	-2.90M
Return on Assets Growth (1y) (Quarter)				0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (3y) (Quarter)												0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (5y) (Quarter)																				0.00M
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)				-169.00	-0.00M	-0.00M	-0.00M	-667.00	-658.00	-503.00	-950.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	74.00	0.00M	0.00M
Return on Capital Employed Growth (3y) (Quarter)												-0.00M	-0.00M	-0.01M	-0.01M	-0.01M	-0.00M	-0.00M	-0.00M	-0.00M
Return on Capital Employed Growth (5y) (Quarter)																				-0.00M
Return on Capital Employed (QoQ) (Quarter)	0.00M	-351.00	-490.00	-460.00	-297.00	-356.00	-16.00	2.00	-287.00	-201.00	-464.00	-383.00	-0.00M	-978.00	-550.00	-354.00	598.00	380.00	735.00	-132.00
Return on Equity Growth (1y) (Quarter)			-1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00	0.00M	0.00M	0.00M	0.00M
Return on Equity Growth (3y) (Quarter)											-1.00	0.00M	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00
Return on Equity Growth (5y) (Quarter)																			-2.00	-1.00
Return on Equity (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Sales Growth (1y) (Quarter)	-898.00		159.00		0.00M	21.00	39.00	20.00	4.00	4.00	6.00	6.00	-4.00	-7.00	0.00M	-6.00	12.00	10.00	6.00	-273.00
Return on Sales Growth (3y) (Quarter)								43.00	152.00		203.00		0.00M	18.00	45.00	20.00	11.00	7.00	11.00	-272.00
Return on Sales Growth (5y) (Quarter)																44.00	160.00		209.00
Return on Sales (QoQ) (Quarter)		0.00M	-22.00	24.00	13.00	6.00	-4.00	5.00	-3.00	6.00	-2.00	6.00	-14.00	3.00	4.00	0.00M	4.00	1.00	1.00	-279.00

Research Tools

Bolt Biotherapeutics Growth Metrics (2020-2026) | BOLT

Create an account

Sign In

Reset Password